White Papers

  1. Inspection Of Injectable Products For Visible Particulates 8/8/2023

    Examine the risks posed by particulates, the potential sources and types of particulates, and approaches to detect and measure visible particulates in injectables.

  2. Critical Considerations For Buffer Preparation 8/7/2023

    Learn about the steps of buffer development, supply approach and strategy selection, choosing between in-house and outsourcing buffer activities, and other related buffer use topics.

  3. Topliss Sets In Drug Design Technical Notes For The Medicinal Chemist 8/3/2023

    When considering new, innovative, and efficient drug design processes, you may want to review Professor J G Topliss's non-mathematical operational schemes for analogue design.

  4. Five Of The Most Useful Transformations In Modern Organic Synthesis 8/3/2023

    The five reactions commonly used in medicinal chemistry are a mix of “traditional” reactions and newer transformations that all share a high level of robustness and flexibility.

  5. Considerations And Strategies For Oligonucleotide Manufacturing Scale-Up 8/2/2023

     To keep up with oligonucleotide demand, manufacturing needs to shift toward larger-scale processes, but this up-scaling process brings challenges that must be addressed.

  6. Switching From Vials To PFS And Intravenous To Subcutaneous Formulations 7/25/2023

    Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient.

  7. Intro To USP <1062> - What It Is And Why You Should Use It 7/20/2023

    Knowing how to use USP <1062> helps manufacturers manage the wide variety of factors that can exacerbate production costs, or result in no product at all.

  8. The Burden Of MES Vendor Cloud Migration In Drug Manufacturing 7/13/2023

    Uncover the challenges and limitations of on-premise MES vendor cloud migration and explore the modern, cloud-based solutions that can circumvent them.

  9. Nasal Vaccine Development, Manufacturing, And Device Selection 7/11/2023

    As you consider developing a nasal delivery program, a partner with experience in development and manufacturing techniques that can see a program through small-scale clinical to commercial supply is crucial.

  10. Spray Drying To Enable New Inhaled Drug Products 7/11/2023

    The formulation and spray drying process can help manufacture a stable, highly respirable powder and deliver products that require a high drug load, a biologic, or rapid onset therapeutic.